Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Chartwell Retirement Residences Unit | 6QD | Nov 25, 2024 | 10.40 | -0.95 |
Charwood Energy S.A. | L5Q | Nov 25, 2024 | 3.02 | 0.00 |
Chatham Rock Phosphate Ltd | 3GRE | Nov 25, 2024 | 0.03 | 0.00 |
Check Point Software Technolgies | CPW | Nov 25, 2024 | 174.00 | +0.75 |
Check-Cap Ltd. - Ordinary Share | 7CC | Nov 25, 2024 | 0.75 | +2.04 |
Checkin.com Group | 7I1 | Nov 25, 2024 | 1.43 | +2.15 |
Checkit Plc | EKC1 | Nov 25, 2024 | 0.19 | 0.00 |
Checkpoint Therapeutics | CZTA | Nov 25, 2024 | 3.55 | -0.84 |
Cheerwin Group Limited | 1RQ | Nov 25, 2024 | 0.21 | +0.95 |
Cheetah Mobile ADR | 0C9 | Nov 25, 2024 | 4.66 | +7.37 |
Chegg Inc | 0CG | Nov 25, 2024 | 2.15 | +11.38 |
Chemed Corp | CXM | Nov 25, 2024 | 545.00 | +1.87 |
Chemical Works of Gedeon Richter Plc. | RIG2 | Nov 25, 2024 | 26.48 | +2.16 |
Chemistree Technology Inc | CM1 | Nov 25, 2024 | 0.00 | 0.00 |
Chemomab Therapeutics Ltd. - American Depositary Shares | 2QV0 | Nov 25, 2024 | 1.54 | +5.48 |
ChemoMetec | CHY | Nov 25, 2024 | 63.25 | +4.81 |
Chemours Company (The) | 2CU | Nov 25, 2024 | 20.41 | +3.95 |
Chemring Group PLC | CMN1 | Nov 25, 2024 | 4.30 | +1.90 |
CHENGDU PUTIAN | CUEH | Nov 25, 2024 | 0.07 | -4.93 |
Cheniere Energy, Inc. | CHQ1 | Nov 25, 2024 | 206.60 | -3.64 |
CHENMING PAPER | SCD1 | Nov 25, 2024 | 0.14 | -1.36 |
Cherry SE | C3RY | Nov 25, 2024 | 0.64 | +3.05 |
Chervon Holdings Limited | AZ9 | Nov 25, 2024 | 1.92 | +0.79 |
Chesapeake Energy Corporation | CS1 | Nov 25, 2024 | 92.82 | -2.91 |
Chesapeake Gold Corp | CKG | Nov 25, 2024 | 0.68 | -2.58 |
Chesapeake Utilities Corporation | CH5 | Nov 25, 2024 | 126.00 | 0.00 |
Chesnara plc | 6DE | Nov 25, 2024 | 2.98 | -0.67 |
CHESSWOOD GROUP | Y3O | Nov 25, 2024 | 0.58 | 0.00 |
CHEUK NANG HOLD | CQH3 | Nov 25, 2024 | 0.17 | -5.08 |
Chevron Corporation | CHV | Nov 25, 2024 | 153.06 | -1.90 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.